Caterina Oneto

Faecal microbiota transplantation for diarrhoea-predominant irritable bowel syndrome: a double-blind, randomised, placebo-controlled trial

Olga C. Aroniadis, Lawrence J. Brandt, Caterina Oneto et al. · ˜The œLancet. Gastroenterology & hepatology · 2019 · 154 citations

Probiotic, Dysbiosis, Intestinal Transplantation +13

Safety and Tolerability of SER-109 as an Investigational Microbiome Therapeutic in Adults With Recurrent <i>Clostridioides difficile</i> Infection

Matthew Sims, Sahil Khanna, Paul Feuerstadt et al. · JAMA Network Open · 2023 · 74 citations · Full text

Perception of quality of life in people experiencing or having experienced a Clostridioides difficile infection: a US population survey

Lise Lurienne, Pierre-Alain Bandinelli, Thibaut Galvain et al. · Journal of Patient-Reported Outcomes · 2020 · 50 citations · Full text

742 - A Double-Blind, Randomized, Placebo-Controlled Trial of Fecal Microbiota Transplantation Capsules (FMTC) for the Treatment of Diarrhea-Predominant Irritable Bowel Syndrome (IBS-D)

Olga C. Aroniadis, Lawrence J. Brandt, Caterina Oneto et al. · Gastroenterology · 2018 · 27 citations

Probiotic, Dysbiosis, Intestinal Transplantation +9

Assessment of Quality of Life Among Patients With Recurrent Clostridioides difficile Infection Treated with Investigational Oral Microbiome Therapeutic SER-109

Kevin W. Garey, Jinhee Jo, Anne J Gonzales-Luna et al. · JAMA Network Open · 2023 · 26 citations · Full text